Skip to content Sermorelin is a growth-hormone-releasing hormone (GHRH) analogue that a licensed provider may consider as part of an individualized, lab-based plan. At Remedy in Maple Grove, MN, it’s prescribed only after evaluation and sourced from a licensed compounding pharmacy.
Sermorelin is a peptide that acts on the pituitary’s GHRH receptors. It is not currently sold as an FDA-approved finished product; a previously approved brand was discontinued by its manufacturer. Today it is prescribed off-label and prepared by licensed compounding pharmacies. Whether it’s appropriate for you is a clinical decision made after your labs and evaluation.
Your provider reviews your bloodwork and health history to determine whether sermorelin is an appropriate option before any prescription is considered.
Because there’s no FDA-approved finished sermorelin product on the market today, your provider explains exactly what off-label prescribing means and answers your questions before you decide.
When sermorelin is appropriate, it’s compounded exclusively by licensed pharmacies that perform batch testing, not sourced from unregulated retail or research-chemical sellers.
Follow-up labs and check-ins are built into your plan, so your provider can track your response over time and adjust care as needed.
Your provider discusses the current evidence supporting sermorelin, along with its limitations, so you can make an informed decision about your care.
Sermorelin is prescribed only within a legitimate provider-patient relationship, never without an evaluation.
After labs and a consultation, your provider determines whether sermorelin is appropriate. If so, they explain the plan, including its off-label nature and the current evidence, obtain informed consent, and arrange pharmacy sourcing. Follow-up labs help track your response.
Bloodwork is completed first, followed by a personalized consultation based on your lab results.
Eligibility assessed; off-label status explained.
If appropriate, prescribed and sourced from a licensed pharmacy.
Periodic reassessment of response.
Are an adult interested in medically supervised, lab-based therapy.
Understand and accept off-label prescribing after your provider explains it.
Prefer pharmacy-sourced, tested products over online research chemicals.
Are in general health with realistic expectations.
Eligibility is determined by your provider.
Sermorelin is prescribed off-label only pursuant to a valid prescription after a legitimate provider–patient relationship, and compounded by a licensed pharmacy. We do not promise specific results and do not sell peptides as retail products. Note: growth-hormone-releasing compounds are prohibited by anti-doping agencies (e.g., WADA); athletes should verify with their governing body.
At Remedy Medical Aesthetics & Wellness in Maple Grove, MN, we provide more than a prescription; we provide clarity and clinical oversight. Patients choose us because:
Your provider grounds any sermorelin recommendation in bloodwork and a clinical evaluation, not guesswork.
Because there is no FDA-approved finished sermorelin product available today, your provider explains exactly what off-label prescribing means before you decide to move forward.
When appropriate, sermorelin is compounded only by licensed pharmacies that perform batch testing, never sourced as an unregulated retail product.
Ongoing monitoring and check-ins are part of your care, helping your provider track your response over time.
There is no FDA-approved finished sermorelin product today; it’s prescribed off-label and compounded by licensed pharmacies. Your provider will explain what that means.
No. Sermorelin is a GHRH analogue, not synthetic growth hormone. Your provider will explain the difference.
Products sold that way are not intended for human use and are not pharmacy-quality. Legitimate sermorelin requires a provider and a licensed pharmacy.
We can’t promise specific outcomes. Your provider will discuss realistic expectations for your situation.
